TickerFacts.

Co-Diagnostics, Inc. (CODX): Cost of Revenue

Annual figures by period end, from SEC filings.

$222.4K
Year ended 2025-12-31
$407.8K
Trailing 12 months to 2026-06-30
-65.6%
3-year compound annual growth
-57.8%
5-year compound annual growth
$16.59M2017-12-31: $3022018-12-31: $9.4K2019-12-31: $112.4K2020-12-31: $16.59M2021-12-31: $11.57M2022-12-31: $5.48M2023-12-31: $4.18M2024-12-31: $999.1K2025-12-31: $222.4K$222.4K
2017-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$222.4K-77.7%2026-03-31, From 2025-01-01
2024-12-31$999.1K-76.1%2026-03-31, From 2024-01-01
2023-12-31$4.18M-23.6%2025-03-27, From 2023-01-01
2022-12-31$5.48M-52.6%2024-03-14, From 2022-01-01
2021-12-31$11.57M-30.2%2023-03-16, From 2021-01-01
2020-12-31$16.59Mn/m2022-03-24, From 2020-01-01
2019-12-31$112.4Kn/m2021-03-25, From 2019-01-01
2018-12-31$9.4Kn/m2020-03-30, From 2018-01-01
2017-12-31$302n/a2019-04-01, From 2017-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Co-Diagnostics, Inc. (CODX)2025-12-31$222.4K-77.7%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31$646.0K+139.3%
Catheter Precision, Inc. (VTAK)2025-12-31$63.0K+50.0%
Sintx Technologies, Inc. (SINT)2025-12-31$557.0K-31.3%
Pulse Biosciences, Inc. (PLSE)2025-12-31$539.0Kn/a
RenovoRx, Inc. (RNXT)2025-12-31$327.0Kn/a
PetVivo Holdings, Inc. (PETV)2026-03-31$386.9K+181.0%
SeaStar Medical Holding Corp (ICU)2025-12-31$53.0Kn/a
QTREX Quantum Ltd. (QTEX)2025-12-31$287.0Kn/a

Compare CODX, HRGN, VTAK, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗